
IndraLab
Statements
reach
"Additional structural information modeling interaction sites for ML323 (as well other USP1 inhibitors) will help define which class of DUB inhibitors this drug falls into and will be instrumental moving forward to improve strategies for selectively targeting the UAF-USP1 complex and potentially other DUBs therapeutically.Key resources and reagents."